> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Former CBER Reviewer Joins NDA Partners
- URL: https://www.fdaweb.com/former-cber-reviewer-joins-nda-partners/
- Published: 2020-12-03T12:00:00.000Z
- Updated: 2026-09-14T16:38:52.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5148224

Former CBER Division of Manufacturing and Product Quality reviewer and investigator **John Godshalk** has joined NDA Partners as an expert consultant. An NDA [announcement](https://www.marketwatch.com/press-release/former-fda-reviewer-and-investigator-division-of-manufacturing-and-product-quality-cber-joins-nda-partners-as-expert-consultant-2020-12-03?tesla=y&ref=fdaweb.com) says Godshalk is an expert in chemistry, manufacturing, and controls, quality, and facility issues for cell and gene therapies, and has experience with biologics, vaccines, drugs, drug/device combinations, biologic devices, and *in vitro* diagnostics.